MiLAB Life Sciences wins Award from AACCI for its Innovative Accomplishment

IMT News Desk
IMT News Desk
· 3 min read
April 11, New Delhi, India: MiLAB Lifesciences, an Ayurvedic pharmaceutical company, ensuring wellness and health for all is conferred by The Asian African Chamber of Commerce and Industry (AACCI) conferred with the award for “Excellence in Ayurvedic and Nutraceutical products” at their flagship summit and business awards in New Delhi, India. The award is presented for implementation of innovative strategies and a futuristic approach towards natural ayurvedic products. The organisers also regarded MiLAB Lifesciences (P) Ltd. as a pioneer of innovation and a leader in the Ayurvedic and Nutraceutical product industry.
The award is presented to Mr. Lakshman Perumal Thirumalai, Founder, MiLAB Lifesciences (P) Ltd. by Mr. Chris Eze, High Commissioner of Federal Republic of Nigeria, H.E. George Mkondiwa, High Commissioner of Mlwai, and Dr. G.D.Singh – Chairman, Asian African Chamber of Commerce & Industry.
The ceremony is known to be the largest business awards ceremony in Asia and Africa and observed presence of high ranking diplomats from various countries. The award entry received a total participation of more than two hundred and fifty professionals from more than forty-four industry sectors.
On receiving the award, Mr. Lakshman Perumal Thirumalai, Founder, MiLAB Lifesciences (P) Ltd. said, “We are delighted and honored to be recognized as a game changer in the Ayurvedic products industry today. The health industry is constantly changing which calls for the creation of innovative products that ensure a healthy lifestyle for all. Being a strong advocate of natural Ayurvedic remedies, we ensure that our team undergoes a rigorous research before formulating the evidence-based Ayurvedic health remedies. With a mission towards encouraging pro-social health behaviors, we aim to make a difference in the lives of people globally through our research-based Ayurveda and natural health products.”
The Summit & Awards, powered by Passion Vista recognizes outstanding leadership and honors the change makers of industries from the Asian-African continent, for their never-ending appetite for perfection, implementing the best practices and moving towards innovative strategies. The award is presented to the innovators of today, who have garnered an impacting position in the industry and society at large.
With an aim to provide a holistic care for the human body, MiLAB offers a diverse range of products catering to different needs of individuals, ranging from weight management to joint-related ailments. MiLAB also caters to heart and diabetic patients with their range of cholesterol and anti-diabetic ayurvedic supplements.
About MiLAB Lifesciences
MiLAB Lifesciences (P) Ltd. is an Ayurvedic pharmaceutical company, ensuring wellness and health for all. MiLAB Lifesciences has an interdisciplinary approach in bringing together diverse Ayurvedic and nutraceutical concepts. MiLAB Lifesciences develops its products through ground zero research, starting with Ayurvedic manuscripts and literature surveys, based on which they create evidence-based Ayurvedic remedies.
MiLAB Lifesciences has a mission towards encouraging pro-social health behaviors. MiLAB believes in the power of collective intelligence and generational wisdom. MiLAB forms strategic, smart networks with people and organizations across clinical practices, scientific and clinical research, academia and industry partners to evolve the best-in-line, certified product. MiLAB does not plan to just limit itself to one nation, it is working with a futuristic vision of being able to cater to people globally and make a difference in their lives through its evidence-based products.

Read Next

Apollo Hospitals Brings Advanced Super Speciality Care in Dadar
News
May 11, 2026

Apollo Hospitals Brings Advanced Super Speciality Care in Dadar

Apollo Hospitals has launched its Super Speciality Center in Dadar, bringing advanced medical care to the heart of Mumbai. The Centre offers super-speciality services across Cardiology, Neurology, Oncology, Gastroenterology, Orthopaedics, Transplantation and Pulmonology, supported by comprehensive diagnostics, robotics-enabled care, and 24×7 clinical access. Nearly 8,000 patients from Mumbai travel to Apollo Hospitals Navi Mumbai every […]
Article by: IMT News Desk
ICMR Invites Pharma Industry To Commercialise Indigenous Cervical Cancer Drug Candidate SHetA2
News
May 11, 2026

ICMR Invites Pharma Industry To Commercialise Indigenous Cervical Cancer Drug Candidate SHetA2

In a major boost to India’s fight against cervical cancer, the Indian Council of Medical Research (ICMR) has invited pharmaceutical companies and eligible organisations to partner in the development and commercialisation of an indigenous cervical cancer drug candidate, SHetA2, designed to treat HPV-induced cervical dysplasia and cervical cancer. ICMR has issued an Expression of Interest […]
Article by: IMT News Desk
Bodywell Ayurveda Earns Global Recognition Through Regulatory Compliance and Strategic Expansion
News
May 11, 2026

Bodywell Ayurveda Earns Global Recognition Through Regulatory Compliance and Strategic Expansion

Homegrown Ayurvedic brand Bodywell Ayurveda is announcing a series of milestones that position it as a regulatory-compliant player on the global wellness stage, built on years of operating within India’s stringent regulatory framework. The company, which holds valid Ayurveda and food manufacturing licences in full compliance with national regulatory standards, is now stocked in over […]
Article by: IMT News Desk
AIIMS Launches Low-Cost Advanced Test to Make Epilepsy Treatment Safer
News
May 11, 2026

AIIMS Launches Low-Cost Advanced Test to Make Epilepsy Treatment Safer

The All India Institute of Medical Sciences (AIIMS) has launched an advanced blood testing service that enables doctors to more accurately treat epilepsy patients and reduce the risk of medicine-related side effects. The new facility at AIIMS’ Neurosciences Centre will monitor the levels of two commonly used anti-epilepsy medicines, levetiracetam and lamotrigine, in a patient’s […]
Article by: IMT News Desk